Kinderhook Industries acquires Enhabit Home Health & Hospice

Kinderhook Industries has acquired Enhabit, a home health and hospice provider, for $1.1 billion, transitioning the company from public to private ownership. Stockholders of Enhabit received $13.80 per share in cash, and the company has been removed from the New York Stock Exchange. The transaction grants Kinderhook control over one of the larger independent operators in the burgeoning home healthcare sector in the U.S.

The acquisition is aligned with efforts to capitalize on rising demand for in-home healthcare services, driven by demographic shifts, escalating healthcare costs, and a growing preference for home-based care. Enhabit, which operates 251 home health locations and 117 hospice sites across 35 states, stands to benefit from the increased operational flexibility and investment support of private ownership. Enhabit CEO, Barbara Jacobsmeyer, emphasized that Kinderhook's resources would bolster the company's growth and clinical capabilities.

For Kinderhook, the deal represents a strategic investment in a sector attractive for its growth potential amidst demographic ageing and a healthcare industry push towards cost-efficient, home-based care models. Jason Michalik, a Managing Director at Kinderhook, highlighted Enhabit's patient-focused approach and strong market position as key factors in the acquisition decision.

The home healthcare and hospice markets have drawn significant interest from private equity due to their role in managing chronic diseases and their alignment with the cost-reduction efforts of insurers and healthcare systems. Consolidation in these markets has been driven by the need for scale, encompassing staffing efficiencies, reimbursement handling, and technological advancements.

Looking ahead, Enhabit may leverage its private status to engage in strategic restructuring and long-term investments free from the short-term performance pressures of the public markets. The transaction is part of Kinderhook’s broader strategy, underpinned by more than $11 billion in capital across varied sectors, including healthcare services. The deal was advised by major financial and legal firms, with Goldman Sachs and Jones Day representing Enhabit, and Guggenheim Securities and Kirkland & Ellis advising Kinderhook.